» Articles » PMID: 35529172

Effect of the Ethanol Extract of Red Okra Pods ( (L.) Moench) to Inhibit Cervical Cancer Cells Growth Through Cell Cycle-Associated Oncogenes

Overview
Publisher Wiley
Specialty Biology
Date 2022 May 9
PMID 35529172
Authors
Affiliations
Soon will be listed here.
Abstract

This study aims to evaluate the potency of ethanol extract of red okra pods (EEROP) in inhibiting growth of cervical cancer cells through repression of the cell cycle-associated oncogenes. The EEROP treatment was given to HeLa cells cultured with RPMI medium and incubated at 37°C with 5% CO. The MTT method was used to measure HeLa cell growth and IC values. The mRNA levels of the three cell cycle-associated oncogenes (, , and ) were evaluated by qRT-PCR to determine the effect of EEROP treatment on the cell cycle. The lowest percentage of viable cells at 24, 48, and 72 hours after EEROP treatment was in the dose of 1000 g/mL with a growth percentage of 71.60% at 24 hours, 55.61% at 48 hours, and 46.97% at 72 hours. The IC values were 2845, 1153, and 776.8 g/mL for 24, 48, and 72 hours, respectively. The three oncogenes at a dose of 1000 g/mL significantly decreased the lowest mRNA levels compared to other doses with oncogene that experienced the greatest decrease. The mRNA level of dose 1000 g/mL EEROP at the oncogene was 0.014-fold changes, at the oncogene was 0.097-fold changes, and at the oncogene was 0.028-fold changes. The EEROP has been shown to decrease the expression of three cell cycle-associated oncogenes. This is also supported by the growth of HeLa cells that did not increase throughout 24, 48, and 72 hours. However, further research is needed on the main active components in red okra that function as anticancer, so that in the future, okra can not only stop cancer cell growth but also induce cancer cell death.

Citing Articles

Ethanolic Extract of Red Okra Pods Induces Aberrant Spindle Segregation and Apoptotic Cell Death by Disrupting the Wnt Signaling Pathway in Colon Cancer Cells.

Dewi F, Wahyuningsih S, Lim V, In L, Hayati A Iran J Med Sci. 2025; 49(12):785-793.

PMID: 39840302 PMC: 11743439. DOI: 10.30476/IJMS.2024.99450.3149.

References
1.
Lin T, Hsu W, Tsai P, Huang Y, Lin C, Chen K . Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial-mesenchymal transition signaling. Food Funct. 2017; 8(4):1558-1568. DOI: 10.1039/c6fo00551a. View

2.
Paulraj F, Abas F, Lajis N, Othman I, Hassan S, Naidu R . The Curcumin Analogue 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells. Molecules. 2015; 20(7):11830-60. PMC: 6331910. DOI: 10.3390/molecules200711830. View

3.
Pang B, Xu X, Lu Y, Jin H, Yang R, Jiang C . Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer. Food Funct. 2019; 10(9):5339-5349. DOI: 10.1039/c9fo01168d. View

4.
Ying H, Jiang H, Liu H, Chen F, Du Q . Ethyl acetate-n-butanol gradient solvent system for high-speed countercurrent chromatography to screen bioactive substances in okra. J Chromatogr A. 2014; 1359:117-23. DOI: 10.1016/j.chroma.2014.07.029. View

5.
Stiasny A, Freier C, Kuhn C, Schulze S, Mayr D, Alexiou C . The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer. Oncol Lett. 2017; 14(4):4467-4476. PMC: 5649573. DOI: 10.3892/ol.2017.6752. View